ALFA Filings
Every announcement, straight from the exchange
Every Fredun Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Fredun Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026. The disclosure provides the equity holding structure for shareholders.
Fredun Pharmaceuticals filed a compliance certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018. It confirms the processing of dematerialized shares for the quarter.
Fredun Pharmaceuticals submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of proceeds from its prior preferential allotment.
Fredun Pharmaceuticals filed its FY26 Annual Secretarial Compliance Report. The auditor noted temporary board composition non-compliance due to an executive director's sudden demise.
Fredun Pharmaceuticals Ltd submitted its quarterly compliance certificate under Regulation 74(5) for the period ended March 31, 2026. The report confirms that 1,000 shares belonging to Nikhil Vora and Sheela Vora were dematerialised during the quarter. This is a routine regulatory filing with no material impact on business operations.